Journal of Clinical Endocrinology & Metabolism, Vol 73, 1134-1140, Copyright © 1991 by Endocrine Society

ARTICLES

3 beta-Hydroxysteroid dehydrogenase activity in glandular and extraglandular human fetal tissues

L Milewich, CE Shaw, KM Doody, WE Rainey, JI Mason and BR Carr
Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas 75235.

The expression of 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) in steroidogenic tissues is an absolute requirement for mammalian reproduction, fetal growth, and life maintenance. We sought to identify extraglandular tissue sites in the human fetus where 3 beta HSD is expressed. To this effect, we conducted in vitro studies by use of homogenates prepared from second trimester fetal tissues. To facilitate the determination of 3 beta HSD activity, an abbreviated technique was developed that consisted in the use of [3 alpha- 3H]dehydroepiandrosterone [( 3 alpha-3H]DHEA) as the substrate and NAD+ as the cofactor. With these reagents, the enzymatic reaction leads to the production of both nonradiolabeled androstenedione and NAD3H in equimolar amounts, and the radioactivity associated with NAD3H is used for quantification of 3 beta HSD activity. The kinetic isotope effect introduced by substitution of tritium for hydrogen at the C-3 alpha position of DHEA, determined with six different tissues, was 2.5 +/- 0.7 (mean +/- SD). The specific activities of the enzyme in peripheral tissues and ovary were relatively low, in the range of 0.03 nmol/mg protein.h for stomach (n = 2) to 0.18 +/- 0.14 nmol/mg protein.h for liver (mean +/- SD; n = 13), while in fetal testis and placenta the specific activities were relatively high, viz. 3.4 +/- 0.7 nmol/mg protein.h (mean +/- SD; n = 4) and 2.8 +/- 1.8 nmol/mg protein.h (mean +/- SD; n = 13), respectively. The findings of this study serve to demonstrate that 3 beta HSD is distributed widely among tissues of the human fetus. Although the enzymatic activity was easily demonstrated in peripheral tissues by the use of radiolabeled DHEA as the substrate, 3 beta HSD protein was not readily detected by Western analysis.

This article has been cited by other articles:

				S. Ben-David, N. Zuckerman-Levin, M. Epelman, Z. Shen-Orr, M. Levin, P. Sujov, and Z. Hochberg Parturition Itself Is the Basis for Fetal Adrenal Involution J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 93 - 97. [Abstract] [Full Text] [PDF]

				T. Suzuki, Y. Miki, Y. Nakamura, T. Moriya, K. Ito, N. Ohuchi, and H. Sasano Sex steroid-producing enzymes in human breast cancer Endocr. Relat. Cancer, December 1, 2005; 12(4): 701 - 720. [Abstract] [Full Text] [PDF]

				K. K. Soma, N. A. Alday, M. Hau, and B. A. Schlinger Dehydroepiandrosterone Metabolism by 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4 Isomerase in Adult Zebra Finch Brain: Sex Difference and Rapid Effect of Stress Endocrinology, April 1, 2004; 145(4): 1668 - 1677. [Abstract] [Full Text] [PDF]

				T. Suzuki, H. Sasano, S. Andersson, and J. I. Mason 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5->4-Isomerase Activity Associated with the Human 17{beta}-Hydroxysteroid Dehydrogenase Type 2 Isoform J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3669 - 3672. [Abstract] [Full Text]

				E. McGee, C. Sawetawan, I. Bird, W. E. Rainey, and B. R. Carr The Effects of Insulin on 3{beta}-Hydroxysteroid Dehydrogenase Expression in Human Luteinized Granulosa Cells Reproductive Sciences, May 1, 1995; 2(3): 535 - 541. [Abstract] [PDF]